Journal article
The quality of phase I trial (P1T) abstracts submitted to ASCO meetings
Abstract
6532
Background: Conference abstracts of P1T communicate important information of anticancer drug development. Our objectives were to determine elements considered by experts as essential for good P1T abstract reporting, to assess the quality of P1T abstracts submitted to ASCO meetings, and to propose guidelines for future reporting. Methods: Elements important for P1T abstract reporting were determined by a survey of experts …
Authors
Strevel EL; Chau N; Pond GR; Murgo AJ; Ivy SP; Siu LL
Journal
Journal of Clinical Oncology, Vol. 25, No. 18_suppl, pp. 6532–6532
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
June 20, 2007
DOI
10.1200/jco.2007.25.18_suppl.6532
ISSN
0732-183X